Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries

PHASE1UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2018

Study Completion Date

May 31, 2018

Conditions
Acute Deep Partial Thickness Thermal Burns
Interventions
DEVICE

Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™)

Application of up to 18 mL of autologous PRP gel (Magellan® Bio-Bandage™) to the surface of an acute deep partial thickness burn wound no greater than 72 cm squared within 72 hours of the initial injury. Intervention is in addition to standard of care treatment. The PRP Bio-Bandage™ is prepared using the Magellan® System and is FDA cleared via BK030040 and BK040068.

Trial Locations (8)

18103

Lehigh Valley Health Network, Allentown

20010

MedStar Health Research Institute, Washington D.C.

27599

Jaycee Burn Center at University of North Carolina, Chapel Hill

33606

Tampa General Hospital/University of South Florida, Tampa

38104

Firefighters' Regional Burn Center, Memphis

85008

Arizona Burn Center, Phoenix

89102

University Medical Center Southern Nevada, Lions Regional Burn Center, Las Vegas

95817

University of California, Davis Medica Center, Sacramento

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

Arteriocyte, Inc.

INDUSTRY

NCT02169362 - Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries | Biotech Hunter | Biotech Hunter